Professional Documents
Culture Documents
Leukemia is cancer of the body's blood-forming tissues, including the bone marrow
and the lymphatic system
Confidential Slide 2
Incidence of Leukemia
Confidential Slide 3
Cause of Leukemia
Smoking
Ionizing Radiation
Down syndrome
Confidential Slide 4
Confidential Slide 5
Clinically and pathologically, leukemia is subdivided into a variety of large groups
Incidence Most common forms of leukemia in mostly occurs in older people, but can
children occur in any age group
Confidential Slide 6
Symptoms of Leukemia
Confidential Slide 7
Symptoms of Leukemia
Leukemia symptoms vary, depending on the type of leukemia. Common leukemia signs and
symptoms include:
Fever or chills
Persistent fatigue, weakness
Frequent or severe infections
Losing weight without trying
Swollen lymph nodes, enlarged liver or spleen
Easy bleeding or bruising
Recurrent nosebleeds
Tiny red spots in your skin (petechiae)
Excessive sweating, especially at night
Bone pain or tenderness
Confidential Slide 8
Diagnosis Tools
Laboratory Tests
A number of laboratory tests may be used to help diagnose leukemia, determine the type, and
monitor the effectiveness of treatment & recurrence of disease
Blood tests:
Complete blood count (CBC) and WBC differential
To count the number, maturity, and proportion of
different types of cells
These tests can provide the first evidence of leukemia
and they are often the first tests ordered to diagnose leukemia
Important tools to monitor the effectiveness of treatment & to detect disease recurrence
Blood smear:
Used to follow up a CBC with abnormal white blood cells, red blood cells or platelets, or with
unclear results
Confidential Slide 9
Other tests:
Bone marrow aspiration/biopsy
Done when the health practitioner suspects leukemia
Involves examination of the marrow sample
(bone and/or fluid) under the microscope
Helps in evaluating the number, size, and appearance of
each of the cell types as well as the proportions of mature
and immature cells
If leukemia is present, the type and severity of the disease
& response to treatment can be determined
Confidential Slide 10
Immunophenotyping or phenotyping by flow cytometry
Helps in diagnosis & classification of leukemia
Cells from the blood, bone marrow, or lymph nodes are incubated with commercially
generated antibodies which selectively bind to antigens on the surface of leukemia cells or in their
cytoplasm. The antigens act like markers and are detected by flow cytometry
Confidential Slide 11
Non Laboratory Tests
Other imaging scans, like ultrasound, may also be used to evaluate the status of
body organs such as the spleen, liver, and kidney
Confidential Slide 12
Treatment
CHEMOTHERAPY
Administration of drugs that kill rapidly dividing cells
Chemotherapy may be taken orally in pill or tablet form,
or it may be delivered via a catheter or intravenous line
directly into the bloodstream
Confidential Slide 13
RADIOTHERAPY
uses high energy radiation to target cancer cells
used in the treatment of leukemia that has spread
to the brain, or it may be used to target the spleen or
other areas where Leukemia cells have accumulated
BIOLOGICAL THERAPY
Help the immune system recognize abnormal cells and then attack them
Include antibodies, tumor vaccines, or cytokines
Monoclonal antibodies are antibodies that react against a specific target
TARGETED THERAPY
Drugs that interfere with one specific property or
function of a cancer cell
This means there is less damage to normal cells
Targeted therapies are given in pill form or by injection
Confidential Slide 14
STEM CELL TRANSPLANT
bone marrow
infusion
Stem cells travel to the bone marrow & begin producing new blood cells
Confidential Slide 15
Autologous Allogeneic
More commonly done Less commonly done
Source of Collected from the patient themselves Cells are taken from a matching donor
Stem Cells
Process Stem cells are removed from the Donors may include a relative/family
patient's blood, harvested, frozen and member (e.g., sibling), unrelated individual,
stored until needed or saved umbilical cord blood
Then given back to the patient after The patient undergoes a human
he/she has received high dose leukocyte antigens (HLA) test - the patient’s
chemotherapy and/or radiation therapy to blood and tissue type with blood samples
destroy the cancer cells from the donor are compared
Advantage Lower incidence of infection Stem cells come from a healthy donor
No immmunosuppression required with no malignant cells
No HLA matching required Lower risk of relapse
Disadvantage Cannot be used in Genetic / Acquired Difficult to find a matching donor
diseases where cells are injured Risk of Graft vs Host Disease
Have higher risk of relapse Treatment related mortality is higher
Confidential Slide 16
Supportive Treatment
Because many of the treatments for leukemia deplete normal blood cells, increasing the
risk for bleeding and infection, supportive treatments may be needed to help prevent
these complications of treatment
It is also needed to help minimize and manage unpleasant side effects of medical or
radiation therapy
Types of supportive and preventive treatments that can be used for patients undergoing
treatment for leukemia include the following:
-- Vaccines against the flu or pneumonia
-- Blood or platelet transfusions
-- Anti-nausea medications
-- Antibiotics or antiviral medications to treat or prevent infections
-- White blood cell growth factors to stimulate white blood cell production
-- Red cell growth factors to stimulate red blood cell production
-- Intravenous injections of Immunoglobulins to help fight infections
Confidential Slide 17
Complications of Leukemia
Frequent infections, bleeding and GVHD (Graft vs Host Disease) in recipients of stem
cell transplants
Weight loss and anemia
Relapse or a progression of the disease after a remission
3% to 5% of cases of CLL may transform into an aggressive lymphoma
Autoimmune hemolytic anemia
People with CLL are also more likely to develop second cancers and other blood
disorders and blood cancers
Confidential Slide 18
Tumor Lysis syndrome is a condition caused by the rapid death of cancer cells when
treated. The rapid destruction of the leukemia cells leads to the release of large
amounts of phosphate, which further causes metabolic abnormalities and can lead to
kidney failure
Children who receive therapy for ALL may experience late adverse effects including
-- Central Nervous System (CNS) impairment
-- Slowing of growth
-- Infertility
-- Cataracts
-- Increased risk for other cancers
Confidential Slide 19
Prognosis
The success of treatment depends on the type of leukemia and the age of the person
Outcomes have improved in the developed world
Outcomes depend on whether
-- it is acute, which is generally more severe, versus chronic
-- the specific abnormal white blood cell type
-- the stage of progression
-- the grade- degree of tissue abnormality;
-- the presence of proximal and/or distant metastasis / lymph node / bone
marrow infiltration
-- the availability of current therapies and the skills of the health care team
Confidential Slide 20
Thank you